MARINELLI ANDREOLI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 232
EU - Europa 194
AS - Asia 187
SA - Sud America 25
AF - Africa 1
Totale 639
Nazione #
US - Stati Uniti d'America 227
SG - Singapore 99
IT - Italia 61
CN - Cina 41
IE - Irlanda 39
HK - Hong Kong 25
DE - Germania 23
BR - Brasile 22
RU - Federazione Russa 21
UA - Ucraina 17
FI - Finlandia 11
VN - Vietnam 9
GB - Regno Unito 5
CA - Canada 4
FR - Francia 4
SE - Svezia 4
IN - India 3
AR - Argentina 2
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
JO - Giordania 2
KR - Corea 2
PL - Polonia 2
TR - Turchia 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IL - Israele 1
MX - Messico 1
NG - Nigeria 1
UZ - Uzbekistan 1
Totale 639
Città #
Singapore 72
Chandler 46
Dublin 39
Perugia 26
Hong Kong 25
San Mateo 18
Ashburn 15
Munich 15
Altamura 13
Beijing 11
Santa Clara 10
Boardman 9
Medford 9
Princeton 9
Jacksonville 8
Lawrence 8
Rome 8
Brooklyn 6
Wilmington 6
Los Angeles 5
Moscow 5
Helsinki 4
Ho Chi Minh City 4
Milan 4
New York 4
Turku 4
Des Moines 3
Redmond 3
Amelia 2
Amman 2
Andover 2
Ankara 2
Atlanta 2
Baku 2
Corridonia 2
Falkenstein 2
Frankfurt am Main 2
Hyderabad 2
Ottawa 2
Redwood City 2
Rouen 2
Seoul 2
Stockholm 2
São Paulo 2
Abuja 1
Ann Arbor 1
Araguaína 1
Ashtabula 1
Baoding 1
Belo Horizonte 1
Bismarck 1
Bragança Paulista 1
Brussels 1
Bắc Ninh 1
Cabo de Santo Agostinho 1
Camanducaia 1
Camapuã 1
Can Tho 1
Capistrano 1
Cepagatti 1
Changsha 1
Chicago 1
Cocalzinho de Goiás 1
Columbus 1
Cumming 1
Curitiba 1
Diadema 1
Florianópolis 1
Guarujá 1
Guarulhos 1
Guilin 1
Haiphong 1
Hanover 1
Hewitt 1
Hải Dương 1
Independence 1
Joinville 1
Lanús 1
London 1
Lucknow 1
Manchester 1
Maringá 1
Miami 1
Montreal 1
Nanjing 1
Napoli 1
Norwalk 1
Nuremberg 1
Oeiras 1
Olomouc 1
Orem 1
Osasco 1
Quincy 1
Rio Grande 1
Rosario 1
Sacramento 1
Saint Petersburg 1
San Paolo di Civitate 1
Sarajevo 1
Savannah 1
Totale 477
Nome #
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 96
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 89
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 79
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 77
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 71
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 71
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 66
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 63
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes. 51
Totale 663
Categoria #
all - tutte 3.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 1 5 0 6 0 2 3
2021/202267 0 11 0 0 1 1 0 19 1 11 14 9
2022/2023139 9 27 6 5 10 18 0 9 49 0 4 2
2023/202466 7 3 3 2 0 5 10 0 6 4 19 7
2024/2025140 0 9 3 17 19 5 2 15 28 7 21 14
2025/2026155 26 14 21 20 64 10 0 0 0 0 0 0
Totale 663